Comment on: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”
Crossref DOI link: https://doi.org/10.1007/s40262-015-0248-4
Published Online: 2015-02-27
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Raschi, Emanuel
Poluzzi, Elisabetta
De Ponti, Fabrizio
Text and Data Mining valid from 2015-02-27